For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260505:nRSE1204Da&default-theme=true
RNS Number : 1204D Craneware plc 05 May 2026
Craneware plc
("Craneware" or the "Company")
Grant of Share Options to Directors
5 May 2026 - The Board of Craneware plc (AIM: CRW.L), a leader in healthcare
financial performance solutions, announces that on 5 May 2026, under the terms
of the Craneware plc SAYE Option Plan (2018) ("the Option Plan"), share
options (the "Options") to acquire ordinary shares of 1p each in the Company
("Shares") were granted to three Directors of the Company as follows:
Director Savings term No. of Shares over which Options granted under the Option Plan Percentage of issued share capital of the Company*
Keith Neilson (CEO) 3 years 1,569 0.005%
Craig Preston (CFO) 3 years 1,569 0.005%
Isabel Urquhart (CPO) 3 years 784 0.002%
*excluding 1,068,553 Shares held in treasury.
The Option Plan is a UK all employee HMRC approved Save As You Earn option
scheme. The Options were granted on the same terms as other UK employees who
chose to participate in the Option Plan. The Options have been granted at an
exercise price of £11.594 per Share. The Options will ordinarily become
exercisable for a period of six months from the end of the savings term.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them:
PDMR notification: Keith Neilson
1. Details of the Restricted Person / person closely associated with him
or her
a)
Name
Keith Neilson
2. Reason for the notification
a) Position /
status
CEO
b) Initial notification / Amendment Initial
notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Craneware plc
b)
LEI
213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of
instrument
Ordinary shares of 1p each in the capital of Craneware plc
b) Identification
code ISIN
GB00B2425G68
c) Nature of the transaction
Grant of share option under the Craneware plc SAYE Option Plan (2018)
d) Price(s) and volume(s)
Volume(s) granted 1,569, Price(s) £11.594
e) Aggregated information:
i.
Aggregated volume Aggregate volume granted 1,569
ii.
Price(s) Price(s) £11.594
f) Date of the transaction
2026-05-05
g) Place of the transaction
Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him
or her
a)
Name
Craig Preston
2. Reason for the notification
a) Position /
status
CFO
b) Initial notification / Amendment Initial
notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Craneware plc
b)
LEI
213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of
instrument
Ordinary shares of 1p each in the capital of Craneware plc
b) Identification
code ISIN
GB00B2425G68
c) Nature of the transaction
Grant of share option under the Craneware plc SAYE Option Plan (2018)
d) Price(s) and
volume(s) Volume(s)
granted 1,569, Price(s) £11.594
e) Aggregated information:
i.
Aggregated volume Aggregate volume granted 1,569
ii.
Price(s) Price(s) £11.594
f) Date of the transaction
2026-05-05
g) Place of the transaction
Outside a trading venue
PDMR notification: Isabel Urquhart
1. Details of the Restricted Person / person closely associated with him
or her
a)
Name
Isabel Urquhart
2. Reason for the notification
a) Position /
status
Chief People Officer
b) Initial notification / Amendment Initial
notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a)
Name
Craneware plc
b)
LEI
213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of
instrument
Ordinary shares of 1p each in the capital of Craneware plc
b) Identification
code ISIN
GB00B2425G68
c) Nature of the transaction
Grant of share option under the Craneware plc SAYE Option Plan (2018)
d) Price(s) and
volume(s) Volume(s)
granted 784, Price(s) £11.594
e) Aggregated information:
i. Aggregated volume
Aggregate volume granted 784
ii. Price(s)
Price(s)
£11.594
f) Date of the transaction
2026-05-05
g) Place of the transaction
Outside a trading venue
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications +44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal craneware@almastrategic.com
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Virginia Bull, Arnav Kapoor
( ) ( )
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Patrick Dolaghan
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus(®) cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHUPUUGAUPQGQA
Copyright 2019 Regulatory News Service, all rights reserved